Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;16(1):145-154.
doi: 10.1016/j.jsmc.2020.10.004. Epub 2020 Dec 7.

What Do We Know About Adherence to Oral Appliances?

Kate Sutherland  1 , Oyku Dalci  2 , Peter A Cistulli  3
Affiliations
Review

What Do We Know About Adherence to Oral Appliances?

Kate Sutherland et al. Sleep Med Clin. 2021 Mar.

Abstract

Long-term effective therapy is essential for obstructive sleep apnea (OSA) control and preventing comorbidity. OSA patients are often reported to be more receptive to oral appliance therapy over positive airway pressure (PAP). Oral appliance usage can now be objectively recorded by temperature microsensors. Studies using commercially available microsensor chips have reported data out to 1 year, with high rates of adherence (>80%), albeit in small samples. There is opportunity to further use this technology to understand individual adherence factors and patterns and in obtaining objective measures of treatment effectiveness, particularly for longer-term health outcomes and allowing comparison to PAP.

Keywords: Compliance monitoring; Mandibular advancement device; Obstructive sleep apnea; Oral appliance; Treatment adherence.

PubMed Disclaimer

Conflict of interest statement

Disclosure K. Sutherland has received in kind support from SomnoMed Australia in the form of donation of oral appliances for investigator-initiated research. P.A. Cistulli holds an endowed academic Chair at the University of Sydney, established through funding from ResMed. P.A. Cistulli has received research support from ResMed, SomnoMed, Zephyr Sleep Technologies, and Bayer. He is a consultant/adviser to Zephyr Sleep Technologies, ResMed, and SomnoMed. He has a pecuniary interest in SomnoMed related to a previous role in R&D (2004). He has received speaker fees from Nox Medical and ResMed. O. Dalci has no conflicts to disclose.

MeSH terms

LinkOut - more resources